Logo image of CRCT

CRICUT INC - CLASS A (CRCT) Stock Fundamental Analysis

USA - NASDAQ:CRCT - US22658D1000 - Common Stock

5.67 USD
+0.12 (+2.16%)
Last: 10/8/2025, 8:00:01 PM
5.56 USD
-0.11 (-1.94%)
After Hours: 10/8/2025, 8:00:01 PM
Fundamental Rating

6

Taking everything into account, CRCT scores 6 out of 10 in our fundamental rating. CRCT was compared to 63 industry peers in the Household Durables industry. CRCT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CRCT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CRCT was profitable.
CRCT had a positive operating cash flow in the past year.
In the past 5 years CRCT has always been profitable.
CRCT had a positive operating cash flow in 4 of the past 5 years.
CRCT Yearly Net Income VS EBIT VS OCF VS FCFCRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

CRCT has a Return On Assets of 9.95%. This is amongst the best in the industry. CRCT outperforms 80.95% of its industry peers.
With an excellent Return On Equity value of 23.25%, CRCT belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 17.73%, CRCT belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRCT is in line with the industry average of 10.32%.
The last Return On Invested Capital (17.73%) for CRCT is above the 3 year average (9.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.95%
ROE 23.25%
ROIC 17.73%
ROA(3y)7.54%
ROA(5y)12.63%
ROE(3y)10.84%
ROE(5y)24.18%
ROIC(3y)9.7%
ROIC(5y)21.39%
CRCT Yearly ROA, ROE, ROICCRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

CRCT's Profit Margin of 10.09% is amongst the best of the industry. CRCT outperforms 82.54% of its industry peers.
CRCT's Profit Margin has improved in the last couple of years.
The Operating Margin of CRCT (11.86%) is better than 74.60% of its industry peers.
CRCT's Operating Margin has been stable in the last couple of years.
CRCT has a Gross Margin of 52.14%. This is amongst the best in the industry. CRCT outperforms 92.06% of its industry peers.
In the last couple of years the Gross Margin of CRCT has grown nicely.
Industry RankSector Rank
OM 11.86%
PM (TTM) 10.09%
GM 52.14%
OM growth 3Y-9.61%
OM growth 5Y-0.51%
PM growth 3Y-6.41%
PM growth 5Y1.82%
GM growth 3Y12.23%
GM growth 5Y11.09%
CRCT Yearly Profit, Operating, Gross MarginsCRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRCT is creating value.
CRCT has less shares outstanding than it did 1 year ago.
CRCT has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CRCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRCT Yearly Shares OutstandingCRCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRCT Yearly Total Debt VS Total AssetsCRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.43 indicates that CRCT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.43, CRCT is in line with its industry, outperforming 55.56% of the companies in the same industry.
CRCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.43
ROIC/WACC1.94
WACC9.15%
CRCT Yearly LT Debt VS Equity VS FCFCRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.52 indicates that CRCT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.52, CRCT is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
A Quick Ratio of 1.21 indicates that CRCT should not have too much problems paying its short term obligations.
CRCT has a Quick ratio of 1.21. This is in the better half of the industry: CRCT outperforms 63.49% of its industry peers.
CRCT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.21
CRCT Yearly Current Assets VS Current LiabilitesCRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2

3. Growth

3.1 Past

CRCT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.45%.
CRCT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.11% yearly.
The Revenue has decreased by -3.98% in the past year.
CRCT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.93% yearly.
EPS 1Y (TTM)6.45%
EPS 3Y-23.19%
EPS 5Y10.11%
EPS Q2Q%22.22%
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y-18.29%
Revenue growth 5Y7.93%
Sales Q2Q%2.48%

3.2 Future

The Earnings Per Share is expected to decrease by -0.10% on average over the next years.
The Revenue is expected to decrease by -0.48% on average over the next years.
EPS Next Y-0.46%
EPS Next 2Y-6.28%
EPS Next 3Y-0.1%
EPS Next 5YN/A
Revenue Next Year-4.36%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRCT Yearly Revenue VS EstimatesCRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CRCT Yearly EPS VS EstimatesCRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.18 indicates a rather expensive valuation of CRCT.
Compared to the rest of the industry, the Price/Earnings ratio of CRCT is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.91, CRCT is valued a bit cheaper.
With a Price/Forward Earnings ratio of 22.26, CRCT is valued on the expensive side.
63.49% of the companies in the same industry are cheaper than CRCT, based on the Price/Forward Earnings ratio.
CRCT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.18
Fwd PE 22.26
CRCT Price Earnings VS Forward Price EarningsCRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRCT is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRCT indicates a rather cheap valuation: CRCT is cheaper than 93.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.79
EV/EBITDA 6.55
CRCT Per share dataCRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CRCT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.7
EPS Next 2Y-6.28%
EPS Next 3Y-0.1%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.16%, CRCT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.76, CRCT pays a better dividend. On top of this CRCT pays more dividend than 87.30% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, CRCT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

CRCT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CRCT Yearly Dividends per shareCRCT Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

180.90% of the earnings are spent on dividend by CRCT. This is not a sustainable payout ratio.
DP180.9%
EPS Next 2Y-6.28%
EPS Next 3Y-0.1%
CRCT Yearly Income VS Free CF VS DividendCRCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M
CRCT Dividend Payout.CRCT Dividend Payout, showing the Payout Ratio.CRCT Dividend Payout.PayoutRetained Earnings

CRICUT INC - CLASS A

NASDAQ:CRCT (10/8/2025, 8:00:01 PM)

After market: 5.56 -0.11 (-1.94%)

5.67

+0.12 (+2.16%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners43.62%
Inst Owner Change0%
Ins Owners8.98%
Ins Owner Change-17.55%
Market Cap1.20B
Analysts40
Price Target4.34 (-23.46%)
Short Float %12.32%
Short Ratio8.84
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly Dividend0.51
Dividend Growth(5Y)N/A
DP180.9%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-07 2025-07-07 (0.75)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)59.22%
Min EPS beat(2)51.89%
Max EPS beat(2)66.55%
EPS beat(4)3
Avg EPS beat(4)39.3%
Min EPS beat(4)-0.47%
Max EPS beat(4)66.55%
EPS beat(8)6
Avg EPS beat(8)37.16%
EPS beat(12)7
Avg EPS beat(12)19.11%
EPS beat(16)7
Avg EPS beat(16)5.98%
Revenue beat(2)2
Avg Revenue beat(2)4%
Min Revenue beat(2)2.35%
Max Revenue beat(2)5.64%
Revenue beat(4)2
Avg Revenue beat(4)-0.27%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)5.64%
Revenue beat(8)2
Avg Revenue beat(8)-3.79%
Revenue beat(12)4
Avg Revenue beat(12)-2.36%
Revenue beat(16)4
Avg Revenue beat(16)-4.26%
PT rev (1m)0%
PT rev (3m)3.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.97%
EPS NY rev (1m)1.89%
EPS NY rev (3m)20.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 17.18
Fwd PE 22.26
P/S 1.69
P/FCF 4.79
P/OCF 4.45
P/B 3.9
P/tB 3.9
EV/EBITDA 6.55
EPS(TTM)0.33
EY5.82%
EPS(NY)0.25
Fwd EY4.49%
FCF(TTM)1.18
FCFY20.89%
OCF(TTM)1.27
OCFY22.47%
SpS3.35
BVpS1.45
TBVpS1.45
PEG (NY)N/A
PEG (5Y)1.7
Profitability
Industry RankSector Rank
ROA 9.95%
ROE 23.25%
ROCE 25.71%
ROIC 17.73%
ROICexc N/A
ROICexgc N/A
OM 11.86%
PM (TTM) 10.09%
GM 52.14%
FCFM 35.35%
ROA(3y)7.54%
ROA(5y)12.63%
ROE(3y)10.84%
ROE(5y)24.18%
ROIC(3y)9.7%
ROIC(5y)21.39%
ROICexc(3y)22.43%
ROICexc(5y)43.81%
ROICexgc(3y)22.44%
ROICexgc(5y)44.35%
ROCE(3y)14.06%
ROCE(5y)31.02%
ROICexcg growth 3Y6.25%
ROICexcg growth 5Y9.03%
ROICexc growth 3Y6.37%
ROICexc growth 5Y9.43%
OM growth 3Y-9.61%
OM growth 5Y-0.51%
PM growth 3Y-6.41%
PM growth 5Y1.82%
GM growth 3Y12.23%
GM growth 5Y11.09%
F-Score7
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 72.96%
Cap/Sales 2.66%
Interest Coverage 250
Cash Conversion 245.12%
Profit Quality 350.45%
Current Ratio 1.52
Quick Ratio 1.21
Altman-Z 3.43
F-Score7
WACC9.15%
ROIC/WACC1.94
Cap/Depr(3y)89.12%
Cap/Depr(5y)121.3%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.9%
Profit Quality(3y)341.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.45%
EPS 3Y-23.19%
EPS 5Y10.11%
EPS Q2Q%22.22%
EPS Next Y-0.46%
EPS Next 2Y-6.28%
EPS Next 3Y-0.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y-18.29%
Revenue growth 5Y7.93%
Sales Q2Q%2.48%
Revenue Next Year-4.36%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.48%
Revenue Next 5YN/A
EBIT growth 1Y-17.08%
EBIT growth 3Y-26.14%
EBIT growth 5Y7.38%
EBIT Next Year39.93%
EBIT Next 3Y17.8%
EBIT Next 5YN/A
FCF growth 1Y6.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.4%
OCF growth 3YN/A
OCF growth 5Y132.5%